Search

everythinglearnresearchcommunity

for

Search:↓

Tildrakizumab significantly improved psoriasis symptoms and well-being over 52 weeks.

The COVID-19 pandemic changed the types of skin conditions seen at a clinic, with fewer patients and varying numbers of specific conditions.

Children with different rheumatologic diseases have specific skin symptoms that can help with diagnosis.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Topical immunotherapy with DPCP is most effective for certain alopecia areata types, with success linked to age and disease duration, and influenced by a gene polymorphism.

Wrinkles form due to structural skin changes and vary in type and treatment response.

Recognizing oral symptoms can help diagnose and treat blood and nutritional diseases early.

Pseudopelade of Brocq is a unique hair loss condition, but its cause and development are still not fully understood.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Scalp psoriasis can cause different types of hair loss, with some patients developing permanent hair loss, and treatment may be stopped due to skin reactions.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

The meeting highlighted the complexity and variability of skin conditions and differing opinions on their diagnoses and treatments.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Significant progress has been made in treating skin, hair, and nail disorders in people with skin of color, but disparities still exist.

Epidermolysis bullosa is a genetic disease causing fragile skin and blisters in both animals and humans.

LiPADI is a useful tool for monitoring the severity and treatment of lichen planus.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Pincer nails are rare in lupus patients and may be managed conservatively.

A boy with Pachyonychia congenita has a confirmed gene mutation, highlighting the need for a local genetic database in India.

JAK inhibitors show promise in effectively treating hair loss from alopecia areata.

Iron is crucial for healthy skin, hair, and nails.

Intralesional steroids are more effective for hair regrowth in alopecia areata than NBUVB, but combining them doesn't improve results.

Eating too much selenium can cause bad breath, hair loss, and nail changes, with harmful effects starting at low daily doses.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Alopecia Areata can affect nails, often improving on its own, but JAK inhibitors may help.

Children with alopecia areata before age 4 may have better short-term hair regrowth.

Oral collagen improves skin, nails, hair, and reduces cellulite.